However, it was shown previously that the sGC activator cinaciguat, when given in high doses, could significantly reduce proteinuria and kidney damage in salt-loaded Dahl rats, a model of salt-sensitive hypertension and CKD (Hoffmann et al., 2015). Here, SGCB is linked to Nephropathy.